Toggle light / dark theme

Dr. Sandeep Patel, Ph.D. — BARDA — Developing Effective Life-Saving Medical Countermeasures For All

Is Director of the Division of Research, Innovation and Ventures (DRIVe — https://drive.hhs.gov/) at the Biomedical Advanced Research and Development Authority (https://aspr.hhs.gov/AboutASPR/ProgramOffices/BARDA/Pages/default.aspx), a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

Dr. Patel is committed to advancing high-impact science, building new products, and launching collaborative programs and initiatives with public and private organizations to advance human health and wellness. As the DRIVe Director, Dr. Patel leads a dynamic team built to tackle complex national health security threats by rapidly developing and deploying innovative technologies and approaches that draw from a broad range of disciplines.

Dr. Patel brings extensive experience in public-private partnerships to DRIVe. Prior to joining the DRIVe team, he served as the HHS Open Innovation Manager. In that role, he focused on advancing innovative policy and funding solutions to complex, long-standing problems in healthcare. During his tenure, he successfully built KidneyX, a public-private partnership to spur development of an artificial kidney, helped design and execute the Advancing American Kidney Health Initiative, designed to catalyze innovation, double the number of organs available for transplant, and shift the paradigm of kidney care to be patient-centric and preventative, and included a Presidential Executive Order signed in July 2019. He also created the largest public-facing open innovation program in the U.S. government with more than 190 competitions and $45 million in awards since 2011.

Prior to his tenure at HHS, Dr. Patel co-founded Omusono Labs, a 3D printing and prototyping services company based in Kampala, Uganda; served as a scientific analyst with Discovery Logic, (a Thomson Reuters company) a provider of systems, data, and analytics for real-time portfolio management; and was a Mirzayan Science and Technology Policy Fellow at The National Academies of Science, Engineering, and Medicine. He also served as a scientist at a nanotechnology startup, Kava Technology.

Dr. Patel holds a US patent issued in 2005 and has authored over a dozen peer-reviewed articles in areas such as nanotechnology, chemistry, innovation policy, and kidney health.

Dr. Patel earned his Ph.D. in physical chemistry from the Georgia Institute of Technology, and has a bachelor’s degree in chemistry from Washington University in St. Louis.

Monica Medina, Assistant U.S. Secretary, Oceans & International Environmental & Scientific Affairs

Monica P. Medina (https://www.state.gov/biographies/monica-p-medina/) is Assistant Secretary for the Bureau of Oceans and International Environmental and Scientific Affairs at the U.S. Department of State. She was also recently appointed as United States Special Envoy for Biodiversity and Water Resources.

Previously, Secretary Medina was an adjunct professor at Georgetown University’s School of Foreign Service. She was also a Senior Associate on the Stephenson Ocean Security Project at the Center for Strategic and International Studies, and Co-Founder and Publisher of Our Daily Planet, an e-newsletter on conservation and the environment.

A former Principal Deputy Under Secretary of Commerce for Oceans and Atmosphere, Secretary Medina served as General Counsel of the National Oceanic and Atmospheric Administration (NOAA), and Special Assistant to the Secretary of Defense. Earlier in her career, Secretary Medina served as the Senior Counsel to former Senator Max Baucus on the Senate Environment and Public Works Committee, as the Senior Director for Ocean Policy at the National Geographic Society, as the ocean lead at the Walton Family Foundation, and in senior roles in other environmental organizations.

Secretary Medina attended college on an Army R.O.T.C. scholarship and began her career on active duty in the Army General Counsel’s Office. She received the Department of Defense Medal for Distinguished Public Service and the Army Meritorious Service Medal. She has a Bachelor’s degree in history from Georgetown University and a J.D. from Columbia Law School.

Book Event: The Fragile Balance of Terror: Deterrence in the Nuclear Age

Please join the Project on Nuclear Issues for a book launch event, featuring “The Fragile Balance of Terror: Deterrence in the Nuclear Age.”

In The Fragile Balance of Terror, edited by Vipin Narang and Scott Sagan, the foremost experts on nuclear policy and strategy offer insight into an era rife with more nuclear powers. Some of these new powers suffer domestic instability, others are led by pathological personalist dictators, and many are situated in highly unstable regions of the world—a volatile mix of variables. The increasing fragility of deterrence in the twenty-first century is created by a confluence of forces: military technologies that create vulnerable arsenals, a novel information ecosystem that rapidly transmits both information and misinformation, nuclear rivalries that include three or more nuclear powers, and dictatorial decision making that encourages rash choices. The nuclear threats posed by India, Pakistan, Iran, and North Korea are thus fraught with danger.
Audience questions: https://forms.gle/t1ecgsgib9hhFjAC8
This event is made possible by general CSIS support.

A nonpartisan institution, CSIS is the top national security think tank in the world.
Visit www.csis.org to find more of our work as we bring bipartisan solutions to the world’s greatest challenges.

Want to see more videos and virtual events? Subscribe to this channel and turn on notifications: https://cs.is/2dCfTve.

Follow CSIS on:
• Twitter: www.twitter.com/csis.
• Facebook: www.facebook.com/CSIS.org.
• Instagram: www.instagram.com/csis/

Artificial Intelligence & the Importance of Civics | Global Stage | GZERO Media

Developing new AI is dangerous. But not doing it is even riskier.


We need more civic education on artificial intelligence, says Eileen Donahoe.

What’s more important to fight AI-enabled disinformation: policies or social norms?

Eileen Donahoe, executive director of Stanford University’s Global Digital Policy Incubator, believes we haven’t done enough on the cultural level and in terms of civic education.

But, should governments ban AI? She’s on the fence when asked during a Global Stage livestream conversation hosted by GZERO in partnership with Microsoft.

Dr. Rob Konrad presenting at Rejuvenation Startup Summit 2022

We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience. If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission. We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience. Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement. You can find more information about the use of your data in our privacy policy. You can revoke or adjust your selection at any time under Settings.

China’s population falls for the first time in over six decades

The decline has come faster than the governments predicted. Will this change China’s stance?

Population in China has dipped for the first time in over 60 years, as per data released by the National Bureau of Statistics today. The country that had 1.41260 billion people in 2021 now has 1.41175 billion at the end of 2022. The small difference in decimals here is actually a difference of 850,000 people on the ground.

The decline in China’s population comes in the backdrop of the country reeling under an intense wave of COVID-19 infections after letting go of its ‘zero-COVID’ policy.


Danielvfung/iStock.

These deaths cannot single-handedly account for the large drop in the population, thereby confirming what population experts have been long predicting: China is set to see a period of negative population growth.

BMC, research in progress

A pioneer of open access publishing, BMC has an evolving portfolio of high quality peer-reviewed journals including broad interest titles such as BMC Biology and BMC Medicine, specialist journals such as Malaria Journal and Microbiome, and the BMC Series.


We use cookies to make sure that our website works properly, as well as some ‘optional’ cookies to personalise content and advertising, provide social media features and analyse how people use our site. By accepting some or all optional cookies you give consent to the processing of your personal data, including transfer to third parties, some in countries outside of the European Economic Area that do not offer the same data protection standards as the country where you live. You can decide which optional cookies to accept by clicking on ‘Manage Settings’, where you can also find more information about how your personal data is processed. Further information can be found in our privacy policy.

Dr Haileyesus Getahun, MD, MPH, PhD — WHO — Leading The Fight Against Antimicrobial Resistance (AMR)

Leading The Global Fight Against Antimicrobial Resistance (AMR) — Dr. Haileyesus Getahun, MD, MPH, Ph.D., Director of AMR Global Coordination, World Health Organization (WHO)


Dr. Haileyesus Getahun, MD, MPH, Ph.D. is Director of AMR (Antimicrobial Resistance) Global Coordination at the World Health Organization (WHO) and the Quadripartite (FAO/UNEP/WHO/WOAH) Joint Secretariat on Antimicrobial Resistance. (https://www.who.int/about/people/biography/dr-haileyesus-getahun)

Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others. Over 1.27 million deaths worldwide were attributed to AMR infections in 2019. Antimicrobials — including antibiotics, antivirals, antifungals and antiparasitics — are medicines used to prevent and treat infections in humans, animals and plants. Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

Dr. Getahun coordinates the global One Health multi-sectoral response to AMR across the human, animal, plant, food, feed and environment sectors; directs the Secretariat of the Global Leaders Group on AMR (https://www.amrleaders.org) currently co-chaired by Their Excellencies Prime Minister of Barbados and Bangladesh; facilitates the research and development agenda through priority setting and gap analysis, and provides policy and programmatic guidance to nurture and scale up evidence-based interventions to enhance antimicrobial stewardship activities, awareness and behavioral change across all sectors.

Dr. Getahun was formerly the Director of the Secretariat of the United Nations Interagency Coordination Group on Antimicrobial Resistance (IACG) which was established by the UN Secretary General and released the 2019 ground-breaking report on how to respond to the global AMR crisis. Before that he worked in the Global TB Program of WHO leading its work on TB/HIV and community care.

/* */